SCHEMBL26420378

SCHEMBL26420378

COc1ccc(Oc2cc3c4c(cc(Oc5ccc(OC)cc5)c5c6ccc(Br)c7cccc(c2c45)c76)C(=O)N(c2c(C(C)C)cccc2C(C)C)C3=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 4/20 0.39
▸ DPP4 P27487 4/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ LMNA P02545 3/20 0.37
▸ GLA P06280 1/20 0.37
▸ NR1H2 P55055 1/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ TP53 P04637 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.35
▸ S1PR2 O95136 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.32
▸ BRD1 O95696 1/20 0.32
▸ TAF1 P21675 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ NPBWR1 P48145 2/20 0.32
▸ LPAR1 Q92633 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15459814 0.94 ANPEP (0.35) ANPEPDPP4KMT2ALMNAGLA
SCHEMBL4582292 0.92 ANPEP (0.41) ANPEPDPP4LMNAGLANR1H2
SCHEMBL7746465 0.90 ANPEP (0.38) ANPEPDPP4LMNAGLANR1H2
SCHEMBL15462870 0.90 ANPEP (0.38) ANPEPDPP4LMNAGLANR1H2
SCHEMBL32670569 0.89 ANPEP (0.46) ANPEPDPP4KMT2ANR1H2NR1H3
SCHEMBL15508968 0.88 ANPEP (0.39) ANPEPDPP4LMNAGLANR1H2
SCHEMBL12414754 0.86 ANPEP (0.37) ANPEPDPP4LMNAGLANR1H2
SCHEMBL3580743 0.86 ANPEP (0.35) ANPEPDPP4LMNAGLANR1H2
SCHEMBL4582896 0.86 CYP1B1 (0.36) ANPEPDPP4LMNANR1H2NR1H3
SCHEMBL15459813 0.85 ANPEP (0.39) ANPEPDPP4KMT2ALMNANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2024-07-04 — — US disclosed
CN-111788206-B Compound and polymer compound containing the same 国立研究开发法人科学技术振兴机构 2024-03-08 — — CN disclosed
US-20230125359-A1 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230125359-A1 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND RAD51, UBE2D3, MDM2 ANPEP 4125/4885DPP4 2527/4885KMT2A 2111/4885
US-20240217976-A2 COMPOUND AND POLYMER COMPOUND CONTAINING THE COMPOUND RAD51, MDM2, UBE2D3 ANPEP 4222/4885DPP4 2449/4885KMT2A 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback